2025 Southern Hemisphere Influenza Vaccine

Awarded Limited / Sole Source Justification Posted

Solicitation number
SPE2DP24R0005
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2DP25D0001 Federal IDV award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical Supply Chain issued a Limited / Sole Source Justification Notice for the procurement of 2025 Southern Hemisphere Influenza Vaccine, awarding contract SPE2DP25D0001 to Sanofi Pasteur Inc. The justification is based on Sanofi Pasteur being the sole FDA-approved manufacturer of the Southern Hemisphere Flu vaccine in the United States. The contract is for a one-year firm fixed price indefinite quantity agreement, with a minimum requirement of 4,500 packages (45,000 doses) and a maximum of 9,000 packages (90,000 doses). The vaccine, Fluzone Southern Hemisphere, is designed for active immunization against influenza virus in persons six months and older, specifically targeting the Southern Hemisphere influenza season from April through October. A Sources Sought Notice was posted on SAM.gov from July 2 to August 2, 2024, which received only two responses: one from Sanofi Pasteur and another from BHPE LLC, though the latter did not provide the requested information. The contract was approved with signatures dated October 7, 2024, and officially awarded on November 27, 2024.

Notice text

Redacted J&A

Awarded contract SPE2DP25D0001 to unknown vendor for unknown amount on 2024-11-27.

Files

File Type Posted
Redacted Southern Hemisphere Flu JA 2025 2026.pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
2025 Southern Hemisphere Influenza Vaccine Latest solicitation Solicitation
2025 Southern Hemisphere Influenza Vaccine Pre-Solicitation
2025 Southern Hemisphere Influenza Vaccine Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors